Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $2.01 Million - $2.31 Million
15,000 New
15,000 $2.01 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $645,000 - $977,900
-10,000 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $629,800 - $757,200
10,000 New
10,000 $757,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Peconic Partners LLC Portfolio

Follow Peconic Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peconic Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peconic Partners LLC with notifications on news.